Case ReportJournal of Pharmacology and PharmacotherapeuticsVol. 12 | Issue 4 | 2022 | pp. 175–176Open access
Ceftriaxone-Induced Thrombocytopenia in a Patient with Bacterial Meningoencephalitis
- 1,
- 1,
- 1,
- 1*,
- 1,
- 1
- 1 Departments of Pharmacy Practice and Internal Medicine, Amrita Institute of Medical Sciences and Research Centre, Kochi, Kerala, India.
Published in Journal of Pharmacology and Pharmacotherapeutics
Correspondence: P. K. Vasant
Departments of Pharmacy Practice and Internal Medicine, Amrita Institute of Medical Sciences and Research Centre, Kochi, Kerala, India.
Email: vpk370@gmail.com
Copyright: © 2022 Manuscript Technomedia LLP. This is an open access article.
- Published:
- Feb 9, 2022
- Received:
- Aug 13, 2021
- Accepted:
- Oct 20, 2021
How to cite
Kumar, A. A., Vijay, V., Arya, M., Vasant, P. K., Chandra, S., & Menon, A. C. (2022). Ceftriaxone-Induced Thrombocytopenia in a Patient with Bacterial Meningoencephalitis. Journal of Pharmacology and Pharmacotherapeutics, 12(4), 175–176. https://doi.org/10.4103/jpp.jpp_106_21
Abstract
Drug-induced thrombocytopenia is a rare and life-threatening condition. It is mainly caused by the initiation of drug-dependent platelet reactive antibodies that leads to the accelerated platelet destruction. Ceftriaxone is a third-generation cephalosporin, which has rarely reported cases of drug-induced immune thrombocytopenia. Here, we report a case of ceftriaxone-induced thrombocytopenia after the initiation of antibiotic therapy for bacterial meningoencephalitis based on the laboratory findings with the initiation and discontinuation of ceftriaxone.
Keywords
Subject
Article metadata
| Title | Ceftriaxone-Induced Thrombocytopenia in a Patient with Bacterial Meningoencephalitis |
|---|---|
| Authors | Anjaly A. Kumar; Vani Vijay; M. Arya; P. K. Vasant; Subhash Chandra; Abhishek C. Menon |
| Affiliations | Departments of Pharmacy Practice and Internal Medicine, Amrita Institute of Medical Sciences and Research Centre, Kochi, Kerala, India. |
| Corresponding author | vpk370@gmail.com |
| Journal | Journal of Pharmacology and Pharmacotherapeutics |
| Volume / Issue | Vol. 12, Issue 4 (2022) |
Also in this issue
- Mucormycosis – The black menace in COVID-19pp. 151–156
- Oliceridine - Breakthrough in the Management of Painpp. 157–162
- Comparison of Serum 25-Hydroxyvitamin D Levels After A Single Oral Dose of Vitamin D3 Formulations in Mild Vitamin D3 Deficiencypp. 163–167
- Impact of Clinical Pharmacist Interventions in Resolving Drug-Related Problems in Patients with Systemic Autoimmune Disorderspp. 168–171
- Monitoring Adverse Drug Reactions and Incidence of Potential Statin-Drug Interactionspp. 172–174
Readers Also Viewed
Development and Validation of UV/visible Spectrophotometric Method for Estimation of Piroxicam from Bulk and Formulation
Sandip Mohan Honmane, Kunal Rajaram Yadav, Yuvraj Dilip Dange
Apr 23, 2025
Effects of Artificial Intelligence on Academic Performance of Library and Information Science University Students: A Meta-Analysis (2023-2025)
Kayode Sunday John Dada
Aug 6, 2026
Bridging Innovation and Impact: A Multidisciplinary Approach to Contemporary Research Challenges
Mueen Ahmed KK
Aug 11, 2026